These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12468107)

  • 1. Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure.
    Dschietzig T; Bartsch C; Pregla R; Zurbrügg HR; Armbruster FP; Richter C; Laule M; Romeyke E; Neubert C; Voelter W; Baumann G; Stangl K
    Regul Pept; 2002 Dec; 110(1):33-8. PubMed ID: 12468107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congestive heart failure and expression of myocardial urotensin II.
    Douglas SA; Tayara L; Ohlstein EH; Halawa N; Giaid A
    Lancet; 2002 Jun; 359(9322):1990-7. PubMed ID: 12076554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cessation of pulmonary and coronary secretion of adrenomedullin peptides in the progression of human heart failure.
    Stangl K; Dschietzig T; Richter C; Stangl V; Bartsch C; Zurbrügg HR; Pregla R; Baumann G; Felix SB; Laule M
    Horm Metab Res; 2002 Feb; 34(2):81-6. PubMed ID: 11972292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary release and coronary and peripheral consumption of big endothelin and endothelin-1 in severe heart failure: acute effects of vasodilator therapy.
    Stangl K; Dschietzig T; Richter C; Laule M; Stangl V; Tanis E; Baumann G; Felix SB
    Circulation; 2000 Sep; 102(10):1132-8. PubMed ID: 10973842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating urotensin II levels in moderate to severe congestive heart failure: its relations with myocardial function and well established neurohormonal markers.
    Gruson D; Rousseau MF; Ahn SA; van Linden F; Ketelslegers JM
    Peptides; 2006 Jun; 27(6):1527-31. PubMed ID: 16364499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure.
    Russell FD; Meyers D; Galbraith AJ; Bett N; Toth I; Kearns P; Molenaar P
    Am J Physiol Heart Circ Physiol; 2003 Oct; 285(4):H1576-81. PubMed ID: 12791592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between urotensin II plasma immunoreactivity and left ventricular filling pressures in coronary artery disease.
    Heringlake M; Kox T; Uzun O; Will B; Bahlmann L; Klaus S; Eleftheriadis S; Armbruster FP; Franz N; Kraatz E
    Regul Pept; 2004 Sep; 121(1-3):129-36. PubMed ID: 15256283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1.
    Hirose T; Takahashi K; Mori N; Nakayama T; Kikuya M; Ohkubo T; Kohzuki M; Totsune K; Imai Y
    Peptides; 2009 Jun; 30(6):1124-9. PubMed ID: 19463745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of urotensin II on vascular tone in normal subjects and patients with chronic heart failure.
    Lim M; Honisett S; Sparkes CD; Komesaroff P; Kompa A; Krum H
    Circulation; 2004 Mar; 109(10):1212-4. PubMed ID: 15007012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The differential extraction and immunoluminometric assay of Urotensin II and Urotensin-related peptide in heart failure.
    Jani PP; Narayan H; Ng LL
    Peptides; 2013 Feb; 40():72-6. PubMed ID: 23270674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligation.
    Bousette N; Hu F; Ohlstein EH; Dhanak D; Douglas SA; Giaid A
    J Mol Cell Cardiol; 2006 Aug; 41(2):285-95. PubMed ID: 16797584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma urotensin II in heart failure.
    Richards AM; Nicholls MG; Lainchbury JG; Fisher S; Yandle TG
    Lancet; 2002 Aug; 360(9332):545-6. PubMed ID: 12241661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma urotensin II levels in patients with diabetes mellitus.
    Totsune K; Takahashi K; Arihara Z; Sone M; Ito S; Murakami O
    Clin Sci (Lond); 2003 Jan; 104(1):1-5. PubMed ID: 12519081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of changes of urotensin II in patients with congestive heart failure].
    Zhong P; Li ZL; Wu HC; Tang CS; Lu Q
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):121-3. PubMed ID: 12581957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal effects of human urotensin-II in rats with experimental congestive heart failure.
    Ovcharenko E; Abassi Z; Rubinstein I; Kaballa A; Hoffman A; Winaver J
    Nephrol Dial Transplant; 2006 May; 21(5):1205-11. PubMed ID: 16396970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urotensin II: a cardiovascular and renal update.
    Zoccali C; Mallamaci F
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):199-204. PubMed ID: 18277155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular distribution of GPR14 and the positive inotropic role of urotensin II in the myocardium in adult rat.
    Gong H; Wang YX; Zhu YZ; Wang WW; Wang MJ; Yao T; Zhu YC
    J Appl Physiol (1985); 2004 Dec; 97(6):2228-35. PubMed ID: 15273242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased gene expression of urotensin II-related peptide in the hearts of rats with congestive heart failure.
    Nakayama T; Hirose T; Totsune K; Mori N; Maruyama Y; Maejima T; Minagawa K; Morimoto R; Asayama K; Kikuya M; Ohkubo T; Hashimoto J; Kohzuki M; Takahashi K; Imai Y
    Peptides; 2008 May; 29(5):801-8. PubMed ID: 18314225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No effect on central or peripheral blood pressure of systemic urotensin II infusion in humans.
    Affolter JT; Newby DE; Wilkinson IB; Winter MJ; Balment RJ; Webb DJ
    Br J Clin Pharmacol; 2002 Dec; 54(6):617-21. PubMed ID: 12492609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure.
    Hystad ME; Geiran OR; Attramadal H; Spurkland A; Vege A ; Simonsen S; Hall C
    Acta Physiol Scand; 2001 Apr; 171(4):395-403. PubMed ID: 11421854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.